1YANG W Y,LU J M,WENG J P. Prevalence of diabetes among men and women in China[J].New England Journal of Medicine,2010,(12):1090-1101.
2HIATT W R. Medical treatment of peripheral arterial disease and claudication[J].New England Journal of Medicine,2001,(21):1608-1621.
3HIRSCH A T,CRIQUI M H,TREAT-JACOBSON D. Peripheral arterial disease detection,awareness,and treatment in primary care[J].Journal of the American Medical Association,2001,(11):1317-1324.
10RESNICK H E,LINDSAY R S,MCDERMOTT M M. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality:the strong heart study[J].Circulation,2004,(06):733-739.
3Amos AF,McCarty PJ,Zimrnet P. The rising globel burden of diabetes and its complications. Estmates and projections to the year 2010 [J]. Diab Med,1997,7(5) :85.
4American Diabetes Association. Standards of medical came for patients with diabetes mellitus [ J ]. Diabetes Care, 2002,25 ( suppl 1 ) :33.
5Okura T, Watanabe S, Kurata M, et al. Relationship between cardio ankle vascular index(CAVI) and carotid atherosclerosis in patients with essential hypertension[J]. Hypertens Res, 2007,30(4) :335 340.
6Parving HH, Lewis JB, Ravid M, et al. DEMAND investigators. Prevalence and risk factors for microalbuminuria in a referred cohort of type 2 diabetic patients: a global perspective[J]. Kidney Int,2006,69(11) : 2057-2063.
7Wang Z, Hoy WE. Albuminuria and incident coronary heart disease in Australian aboriginal people[J]. Kidney Int,2005, 68(3) : 1289-1293.
8Tseng CH,Huang YK, Huang YL, et al. Arsenic exposure, urinary arsenic speciation and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan[J]. Toxicol Appl Pharmacol,2005,206(3) : 299-308.
9Tapp RJ, Shaw JE, de Courten MP, et al. AusDiab study group. Foot complications in Type 2 diabetes: an Australian population-based study[J]. Diabet Med, 2003,20 (2) : 105-113.
10Kallio M,Forsblom C, Groop PH, et al. Development of new peripheral arterial occlusive disease in patients with type 2 diabetes during a mean follow up of 11 years[J]. Diabetes Care,2003,26(4): 1241-1245.
